Hypoallergenicity of A Whey-Based, Extensively Hydrolysed Formula Containing Two Structurally Identical Human Milk Oligosaccharides
Abstract:
To determine whether an extensively hydrolyzed formula (EHF) supplemented with two human milk oligosaccharides (HMO) was tolerated by infants with cow’s milk protein allergy (CMPA).
Methods:
A whey-based EHF (Test formula) containing 2′fucosyl-lactose (2′FL) and lacto-N-neotetraose (LNnT) was assessed for clinical hypoallergenicity and safety. The Control formula was a cur...
Tags
This article's user rating is
Authors
Professor Anna Nowak-Wegrzyn
Dr Laura Czerkies
Kemuel Reyes
Dr Barbara Collins
Dr Ralf G. Heine
Related case studies
Professor Anna Nowak-Wegrzyn
Dr. Laura Czerkies
Dr. Martinas Kuslys
Dr. Sophie Nutten
Dr. Peter J. Simons
Dr. Barbara Collins
Dr. Ralf G. Heine
Dr. Bodo Niggemann
Dr. Andrea von Berg
Dr. Dietrich Berdel
Dr. U Schauer
Dr. Christoph Rieger
Dr. Elisabeth Haschke-Becher
Professor Ulrich Wahn
Related Content
Professor Yvan Vandenplas
Dr. Marta Żołnowska
Dr. Roberto Berni Canani
Dr. Sian Ludman
Dr. Tengelyi Zsuzsanna
Dr. Moreno Álvarez
Dr. Anna Goh
Dr. Laura Gosoniu
Dr. Monika Tadi
Dr. Ralf Heine
Professor Anna Nowak-Wegrzyn
Related Products
